Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)
Avalo Therapeutics (AVTX) posted Inventory Average of $18500.0 for Q2 2023, down 5.13% on a QoQ basis from $19500.0 in Q1 2023, and down 22.92% year-over-year from $24000.0 in Q2 2022.
Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023) Analysis & Trends
Avalo Therapeutics' Inventory Average history runs 6 years deep, the most recent figure standing at $18500.0 for Q2 2023.
- Quarterly Inventory Average fell 22.92% year-over-year to $18500.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $18500.0 (down 22.92% YoY) and the FY2022 annual result came in at $29000.0, up 41.46% from the prior year.
- Inventory Average was $18500.0 for Q2 2023 at Avalo Therapeutics, down from $19500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $682452.5 in Q1 2019 and bottomed at $6030.0 in Q4 2020.
- A 5-year average of $80425.1 and a median of $20250.0 in 2022 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2020 — Inventory Average tumbled 97.24% — and 2021, when it surged 347.76%.
- Avalo Therapeutics' Inventory Average stood at $211800.5 in 2019, then slumped by 97.15% to $6030.0 in 2020, then jumped by 347.76% to $27000.0 in 2021, then dropped by 22.22% to $21000.0 in 2022, then decreased by 11.9% to $18500.0 in 2023.
- Business Quant data shows AVTX's Inventory Average at $18500.0 in Q2 2023, $19500.0 in Q1 2023, and $21000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 644.91 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 18,500.00 |
| Mar 31, 2023 | 19,500.00 |
| Dec 31, 2022 | 21,000.00 |
| Sep 30, 2022 | 22,500.00 |
| Jun 30, 2022 | 24,000.00 |
| Mar 31, 2022 | 31,500.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Dec 31, 2020 | 6,030.00 |
| Sep 30, 2020 | 10,628.00 |
| Jun 30, 2020 | 14,236.00 |
| Mar 31, 2020 | 18,805.00 |
| Dec 31, 2019 | 211,800.50 |
| Mar 31, 2019 | 682,452.50 |
| Dec 31, 2018 | 691,196.00 |
| Sep 30, 2018 | 1.30 Mn |
| Jun 30, 2018 | 2.49 Mn |
| Mar 31, 2018 | 1.91 Mn |